Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCA | P06881 | 2/20 | 0.63 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
| ▸ | GLP1R | P43220 | 8/20 | 0.60 |
| ▸ | CCKBR | P32239 | 2/20 | 0.60 |
| ▸ | CALCR | P30988 | 4/20 | 0.59 |
| ▸ | NPY1R | P25929 | 1/20 | 0.57 |
| ▸ | NPY2R | P49146 | 1/20 | 0.57 |
| ▸ | NPY4R | P50391 | 1/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.57 |
| ▸ | GIPR | P48546 | 5/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30831408 | 0.90 | NPY1R (0.68) | CXCR4GLP1RCCKBRCALCRNPY1R | |
| SCHEMBL30712903 | 0.89 | CXCR4 (0.65) | CALCACXCR4GLP1RCCKBRCALCR | |
| SCHEMBL10587346 | 0.88 | CXCR4 (0.65) | CXCR4GLP1RCCKBRCALCRNPY1R | |
| SCHEMBL31073551 | 0.87 | NPY1R (0.69) | CALCAGLP1RCCKBRCALCRNPY1R | |
| SCHEMBL30906530 | 0.87 | CALCA (0.54) | CALCACXCR4GLP1RNPY1RNPY2R | |
| SCHEMBL30567740 | 0.87 | GLP1R (0.70) | CXCR4GLP1RCCKBRCALCRNPY1R | |
| SCHEMBL30958882 | 0.87 | CALCR (0.69) | GLP1RCCKBRCALCRNPY1RNPY2R | |
| SCHEMBL30485540 | 0.87 | NPY1R (0.68) | CALCACXCR4GLP1RCCKBRCALCR | |
| SCHEMBL30712940 | 0.86 | GLP1R (0.68) | CXCR4GLP1RCCKBRCALCRNPY1R | |
| SCHEMBL30658391 | 0.86 | NPY2R (0.70) | CXCR4GLP1RCCKBRCALCRNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118109369-A | Bacteriocin-producing bacillus subtilis subspecies and composite microbial inoculum, and preparation method and application thereof | 中国海洋大学 | 2024-05-31 | — | — | CN | claimed |
| CN-114081098-B | Method for preparing composite immunopotentiator from Subtilosin A and dandelion root polysaccharide and application thereof | 淮阴工学院 | 2024-04-19 | — | — | CN | claimed |
| CN-114081098-A | Method for preparing compound immunopotentiator from Subtilosin A and dandelion root polysaccharide and application thereof | 淮阴工学院 | 2022-02-25 | — | — | CN | claimed |
| EP-4719446-A1 | PROBIOTIC DERIVED COMPOUNDS THAT INHIBIT BIOFILM FORMATION AND IMPROVE ANTIBIOTIC SENSITIVITY AGAINST STAPHYLOCOCCUS AUREUS AND USES THEREOF | Marquette University (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12594307-B2 | Compositions and methods of using inducible signaling for tunable dynamics in microbial communities | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | disclosed |
| CN-120366131-B | Bacillus subtilis, microbial agent thereof and application of microbial agent in preventing and treating bacterial angular leaf spot of cucumber | 河北大学 | 2026-03-13 | — | — | CN | disclosed |
| CN-120391463-B | Application of bacillus subtilis in preventing and controlling plant diseases and microbial agent prepared by using bacillus subtilis | 河北大学 | 2026-01-30 | — | — | CN | disclosed |
| US-20250376709-A1 | PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL | UNIV UTAH RES FOUND (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4308135-B1 | THERAPEUTIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | ELIGO BIOSCIENCE (FR) | 2025-12-03 | — | — | EP | disclosed |
| US-20250344703-A1 | AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA | BIOCONSORTIA, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250338854-A1 | AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA | BIOCONSORTIA, INC. (US) | 2025-11-06 | — | — | US | disclosed |
| EP-3983557-A1 | PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES IN BACILLUS | Chr. Hansen HMO GmbH (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-3984366-A1 | CONTROLLED GROWTH OF MICROORGANISMS | Syngulon SA (BE) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022067052-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | ELANCO US INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| US-20220088090-A1 | MICROBIOME RELATED IMMUNOTHERAPIES | FINCH THERAPEUTICS HOLDINGS LLC | 2022-03-24 | — | — | US | disclosed |
| US-20220088082-A1 | Compositions and Method for Treating Primary Sclerosing Cholangitis and Related Disorders | FINCH THERAPEUTICS HOLDINGS LLC (US) | 2022-03-24 | — | — | US | disclosed |
| CN-114081098-A | Method for preparing compound immunopotentiator from Subtilosin A and dandelion root polysaccharide and application thereof | 淮阴工学院 | 2022-02-25 | — | — | CN | disclosed |
| CN-114081098-A | Method for preparing compound immunopotentiator from Subtilosin A and dandelion root polysaccharide and application thereof | 淮阴工学院 | 2022-02-25 | — | — | CN | disclosed |
| CN-114081098-A | Method for preparing compound immunopotentiator from Subtilosin A and dandelion root polysaccharide and application thereof | 淮阴工学院 | 2022-02-25 | — | — | CN | disclosed |
| US-20220031773-A1 | Methods and Compositions for Treating Ulcerative Colitis | FINCH THERAPEUTICS HOLDINGS LLC (US) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220088090-A1 | MICROBIOME RELATED IMMUNOTHERAPIES | ICOS, CD274, PDCD1 | CALCA 141/4885CXCR4 1475/4885GLP1R 2835/4885 |
| US-12594307-B2 | Compositions and methods of using inducible signaling for tunable dynamics in microbial communities | COASY, MRPL21, SPOUT1 | CALCA 3882/4885CXCR4 4590/4885GLP1R 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.